NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 59 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,515,000 | +291.9% | 12,738,000 | +373.9% | 0.00% | +200.0% |
Q2 2020 | $4,469,000 | -65.1% | 2,688,000 | -73.1% | 0.00% | -75.0% |
Q1 2020 | $12,815,000 | +67.4% | 10,000,000 | +100.0% | 0.00% | +100.0% |
Q4 2019 | $7,656,000 | – | 5,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |